PepGen (PEPG) Receivables - Other (2021 - 2023)

PepGen (PEPG) reported Receivables - Other of -$1000.0 for Q4 2023, up 99.98% on a YoY basis from -$500.06 in Q4 2022, and up 99.98% sequentially from -$4.2 million in Q4 2022.

PepGen (PEPG) Receivables - Other (2021 - 2023) Analysis & Trends

PepGen (PEPG) has 3 years of Receivables - Other data on file, last reported at -$1000.0 in Q4 2023.

  • For the quarter ending Q4 2023, Receivables - Other rose 99.98% year-over-year to -$1000.0; the trailing twelve-month figure through Dec 2023 stood at -$176000.0 (down 165.67% YoY), and the FY2023 full-year result was -$26000.0, up 99.38% from the prior year.
  • Receivables - Other rose to -$1000.0 in Q4 2023, from -$4.2 million in the prior quarter.
  • In the past five years, Receivables - Other ranged from a high of $4.6 million in Q1 2022 to a low of -$4.2 million in Q4 2022.
  • A 3-year average of $1.4 million and a median of $768000.0 in 2021 frame the typical range for Receivables - Other.
  • Peak annual rise in Receivables - Other reached 6040.26% in 2022, while the deepest fall reached 640.49% in 2022.
  • Tracing PEPG's Receivables - Other over 3 years: stood at $768000.0 in 2021, then sank by 640.49% to -$4.2 million in 2022, then jumped by 99.98% to -$1000.0 in 2023.
  • Business Quant data shows PEPG's Receivables - Other at -$1000.0 in Q4 2023, -$4.2 million in Q4 2022, and $3.9 million in Q3 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 PepGen 145.09 Mn 145.09 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2023 -1,000.00
Dec 31, 2023 -1,000.00
Dec 31, 2022 -4.15 Mn
Dec 31, 2022 -4.15 Mn
Sep 30, 2022 3.88 Mn
Sep 30, 2022 3.88 Mn
Jun 30, 2022 4.23 Mn
Jun 30, 2022 4.23 Mn
Mar 31, 2022 4.57 Mn
Mar 31, 2022 4.57 Mn
Dec 31, 2021 768,000.00
Dec 31, 2021 768,000.00
Sep 30, 2021 3.21 Mn
Sep 30, 2021 3.21 Mn
Jun 30, 2021 443,000.00
Jun 30, 2021 443,000.00
Mar 31, 2021 -77,000.00
Mar 31, 2021 -77,000.00